Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -113.00p -1.79% 6,204.00p 6,207.00p 6,208.00p 6,262.00p 6,079.00p 6,182.00p 3,294,458 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16,632.7 1,648.8 175.5 33.4 78,580.70

AstraZeneca Says Phase 3 Trial Results for Imfinzi Antibody Delayed

12/03/2018 7:42am

Dow Jones News

AstraZeneca (LSE:AZN)
Historical Stock Chart

1 Year : From Nov 2017 to Nov 2018

Click Here for more AstraZeneca Charts.
   By Adria Calatayud 

AstraZeneca PLC (AZN.LN) said Monday that the results of a phase 3 clinical trial for its Imfinzi antibody will be delayed until the second half of the year.

The pharmaceutical company said it had previously expected to release the results of the clinical trial in the first half. It didn't provide details on the cause of the delay.


Write to Adria Calatayud at


(END) Dow Jones Newswires

March 12, 2018 03:27 ET (07:27 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year AstraZeneca Chart

1 Year AstraZeneca Chart

1 Month AstraZeneca Chart

1 Month AstraZeneca Chart
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20181116 17:43:32